Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pang

Showing results (711-720 of 824) with videos related to

Pageof 83
Sort By:
Journal of the American College of Cardiology|March 17, 2018
N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED StudyJames L Januzzi, Annabel A Chen-Tournoux, Robert H Christenson, et al.
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
Hawaii Medical Journal|June 16, 2006
Evaluation of secondhand smoking characteristics in asthmatic children presenting to four emergency departments on O'ahu, Hawai'iRodney B Boychuk, Brunhild M Halm, Francisco Garcia, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
International Journal of Cardiology|January 8, 2018
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHFMarco Metra, Beth A Davison, Claudio Gimpelewicz, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
American Heart Journal|March 31, 2015
Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trialJames L Januzzi, Umesh Sharma, Pearl Zakroysky, et al.
AIDS (London, England)|July 18, 2020
Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockadeIvo N SahBandar, Glen M Chew, Michael J Corley, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
Pest Management Science|November 3, 2011
The structure-activity relationship in herbicidal monosubstituted sulfonylureasZheng-Ming Li, Yi Ma, Luke Guddat, et al.
Pageof 83

Showing results (711-720 of 824) with videos related to

Sort By:
Pageof 83
Journal of the American College of Cardiology|March 17, 2018
N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED StudyJames L Januzzi, Annabel A Chen-Tournoux, Robert H Christenson, et al.
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
Hawaii Medical Journal|June 16, 2006
Evaluation of secondhand smoking characteristics in asthmatic children presenting to four emergency departments on O'ahu, Hawai'iRodney B Boychuk, Brunhild M Halm, Francisco Garcia, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
International Journal of Cardiology|January 8, 2018
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHFMarco Metra, Beth A Davison, Claudio Gimpelewicz, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
American Heart Journal|March 31, 2015
Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trialJames L Januzzi, Umesh Sharma, Pearl Zakroysky, et al.
AIDS (London, England)|July 18, 2020
Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockadeIvo N SahBandar, Glen M Chew, Michael J Corley, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
Pest Management Science|November 3, 2011
The structure-activity relationship in herbicidal monosubstituted sulfonylureasZheng-Ming Li, Yi Ma, Luke Guddat, et al.
Pageof 83